Preopioid Versus Nonopioid in Total Knee Arthroplasty (TKA)
Acute Pain After Fast-track Total Knee Arthroplasty: Preoperative Opioid Versus Non-opioid
1 other identifier
observational
140
1 country
4
Brief Summary
Observational study evaluating pain response after total knee arthroplasty (TKA) in patients taking strong, weak or no opioids preoperatively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2011
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedFirst Submitted
Initial submission to the registry
March 24, 2011
CompletedFirst Posted
Study publicly available on registry
March 25, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2013
CompletedJune 5, 2013
June 1, 2013
1.9 years
March 24, 2011
June 4, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain
Pain during ambulation and at rest
24 hours
Secondary Outcomes (2)
Pain
7 days
Opioid consumption
7 days
Study Arms (3)
Strong opioids
Patients taking strong opioids preoperatively
Weak opioids
Patients taking weak opioids preoperatively
Opioid native
Patients not taking opioids preoperatively
Eligibility Criteria
Patients operated with elective, primary, unilateral total knee artroplasty (TKA).
You may qualify if:
- Patients operated with elective, primary, unilateral total knee arthroplasty (TKA) (taking strong or weak opioid daily for minimum 4 weeks or opioid naive patients)
You may not qualify if:
- Bilateral / revision arthroplasty
- Disease affection central or peripheral nerve function
- Alcohol and medical abuse
- Daily use of glucocorticoids
- Malignancy
- BMI \> 40
- Dementia or other cognitive dysfunction
- Treatment of anxiety or depression
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Dep. of ortopedic surgery, Gentofte Hospital
Hellerup, Hellerup, 2900, Denmark
Dep. of ortopedic surgery, Regionshospitalet Holstebro
Holstebro, Holstebro, 7500, Denmark
Dep. of Anesthesiology, Hvidovre University Hospital
Copenhagen, Hvidovre, 2650, Denmark
Dep. of ortopedic surgery, Vejle Sygehus
Vejle, Vejle, 7100, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Troels H Lunn, MD
Dep. of Anesthesiology, Hvidovre University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
March 24, 2011
First Posted
March 25, 2011
Study Start
March 1, 2011
Primary Completion
February 1, 2013
Study Completion
February 1, 2013
Last Updated
June 5, 2013
Record last verified: 2013-06